How concerned should we be over the long-term safety of growth hormone therapy?

Lancet Diabetes Endocrinol. 2017 Feb;5(2):79-81. doi: 10.1016/S2213-8587(16)30423-5. Epub 2016 Dec 21.

Author

Nicholas A Tritos¹

Affiliation

¹ Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA. Electronic address: ntritos@mgh.harvard.edu.

PMID: 28011066
DOI: 10.1016/S2213-8587(16)30423-5

No abstract available

Publication types

Comment

MeSH terms

Gestational Age
Growth Hormone*
Human Growth Hormone*
Humans
Infant, Newborn
Infant, Small for Gestational Age
Longitudinal Studies
Young Adult

Substances

Human Growth Hormone
Growth Hormone